Teva : Manageable legal backdrop provides good buying opportunities
Teva's spreads have slightly underperformed peers, driven by mixed legal developments with the group settling a number of cases on favourable terms but failing to reach a final resolution in the crucial opioid case. Spreads hit a one-year high in December in the wake of the New York State liable verdict but rapidly subsided as the group in February settled claims in Texas on terms mirroring a possible upcoming national framework. Currently, spreads remain more than 150bp wider th...Teva Pharmaceutical Industries is engaged in the development, manufacturing, marketing and distribution of generic, specialty, and other pharmaceutical products. The Generic Medicines segment offers a range of basic chemical entities, as well as specialized product families such as sterile products, hormones, narcotics, high-potency drugs and cytotoxic substances, in both parenteral and solid dosage forms. Co.'s specialty medicines business is focused on delivering innovative solutions to patients and providers via medicines, devices and services, includes Co.'s core therapeutic areas of the central nervous system and respiratory medicines.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.